Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy
Status:
Active, not recruiting
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Gathering information about how young patients with ependymoma respond to standard
combination chemotherapy and learning about the long-term effects of this treatment may help
doctors plan better treatment.
PURPOSE: This phase III trial is observing young patients with ependymoma undergoing standard
combination chemotherapy.